Vanguard Health Care ETF (VHT)

Add to Watchlists
Create an Alert
117.78 +1.54  +1.32% NYSE Arca Oct 23, 9:47AM BATS Real time Currency in USD
View Full Chart
VHT Price Chart

VHT Description

Vanguard Health Care ETF is a long only equity fund managed by Vanguard that tracks the MSCI US IMI/Health Care 25-50 GR USD index and has 3.447B USD assets under management. It has an expected distribution yield of 0.96%, a Forecasted PE Ratio of 20.19, and a Forecasted Price to Book Value of 3.499. The fund has a net expense ratio of 0.14%, turns over its positions 5.00% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: MSCI US IMI/Health Care 25-50 GR USD

VHT Key Info

Expense Ratio (12-23-13) 0.14%
Assets Under Management (10-17-14) 3.447B
30-Day Average Volume (10-22-14) 378340.4
Net Asset Value (10-21-14) 116.85
Discount or Premium to NAV (10-17-14) 0.01%
Turnover Ratio (8-31-13) 5.00%

VHT Asset Allocation

Type % Net % Long % Short
Cash 0.33% 0.33% 0.00%
Stock 99.67% 99.67% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 30, 2014

VHT Region Exposure

Americas 99.71%
North America 99.69%
Latin America 0.02%
Greater Europe 0.25%
United Kingdom 0.00%
Europe Developed 0.25%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.04%
Japan 0.00%
Australasia 0.04%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of Sept. 30, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

VHT Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.03%
Energy 0.00%
Financial Services 0.07%
Healthcare 98.46%
Industrials 0.29%
Real Estate 0.00%
Technology 1.15%
Utilities 0.00%
As of Sept. 30, 2014

VHT Stock Market Capitalization

Giant 48.68%
Large 32.49%
Medium 12.31%
Small 4.37%
Micro 1.82%
As of Sept. 30, 2014
View More Holdings

VHT Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 10.37% 102.37 +1.14%
Pfizer Inc 6.48% 28.64 +1.18%
Merck & Co Inc 5.96% 56.54 +1.86%
Gilead Sciences Inc 5.62% 106.35 +0.25%
Amgen Inc 3.67% 146.46 +1.96%
AbbVie Inc 3.17% 58.44 +2.71%
Bristol-Myers Squibb Company 2.92% 52.34 +0.96%
UnitedHealth Group Inc 2.91% 90.60 +0.92%
Biogen Idec Inc 2.71% 312.29 +1.04%
Celgene Corp 2.62% 96.65 +1.99%
As of Sept. 30, 2014
Get Quote for
Advertisement

VHT Risk Info

Beta 0.7652
30 Day Average Volatility 19.59%

VHT Fundamentals

Dividend Yield TTM (10-23-14) 0.96%
Weighted Average PE Ratio 24.91
Weighted Average Price to Sales Ratio 1.914
Weighted Average Price to Book Ratio 3.939
Weighted Median ROE 18.30%
Weighted Median ROA 7.52%
Forecasted Dividend Yield 1.35%
Forecasted PE Ratio 20.19
Forecasted Price to Sales Ratio 1.847
Forecasted Price to Book Ratio 3.499
Number of Holdings 304.00
As of Sept. 30, 2014

VHT Growth Estimates

Forecasted 5 Yr Earnings Growth 9.79%
Forecasted Book Value Growth 8.76%
Forecasted Cash Flow Growth 1.09%
Forecasted Earnings Growth -13.02%
Forecasted Revenue Growth 7.51%
As of Sept. 30, 2014

VHT Performance

  Returns Total Returns
1M -0.39% -0.39%
3M 4.69% 4.69%
6M 11.37% 11.37%
1Y 21.74% 23.13%
3Y 98.92% 108.1%
5Y 127.5% 148.7%
As of Oct. 21, 2014

VHT Flows

1M 140.90M
3M 266.65M
6M 138.36M
YTD 637.75M
1Y 836.14M
3Y 1.664B
5Y 1.711B
As of Sept. 30, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.